Ironwood Pharmaceuticals (IRWD) Other Working Capital Changes (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$621000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$621000.0, down 8.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$416000.0 (up 81.3% YoY), and the FY2025 annual result was -$367000.0, up 83.13% from the prior year.
• Other Working Capital Changes came in at -$621000.0 for Q1 2026 at Ironwood Pharmaceuticals, down from $1.4 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $3.1 million in Q2 2024 to a low of -$3.1 million in Q4 2024.
• The 5-year median for Other Working Capital Changes is -$523000.0 (2024), against an average of -$176352.9.
• Peak annual rise in Other Working Capital Changes reached 424.39% in 2024, while the deepest fall reached 1837.04% in 2024.
• Ironwood Pharmaceuticals' Other Working Capital Changes stood at $1.4 million in 2022, then gained by 26.18% to $1.8 million in 2023, then plunged by 275.03% to -$3.1 million in 2024, then jumped by 144.23% to $1.4 million in 2025, then slumped by 144.61% to -$621000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$621000.0 (Q1 2026), $1.4 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.